• Females who are heterozygous for adrenoleukodystrophy (ALD) can be identified biochemically. Since most carriers for this disease are asymptomatic, their diagnosis usually occurs only after neurologically abnormal male relatives have been investigated. We describe a woman with a chronic nonprogressive spinal cord syndrome secondary to the ALD heterozygote state. The neurologic condition in this patient suggests that the diagnosis of ALD should be considered in women with evidence of white matter disease.
Noetzel MJ, Landau WM, Moser HW. Adrenoleukodystrophy Carrier State Presenting as a Chronic Nonprogressive Spinal Cord Disorder. Arch Neurol. 1987;44(5):566–567. doi:10.1001/archneur.1987.00520170092031
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.